Impaired coronary microvascular function is linked to cardiometabolic risk factors and predicts faster atherosclerosis progression in asymptomatic middle-aged individuals.
In asymptomatic middle-aged individuals free of known cardiovascular disease, the presence of cardiometabolic risk factors and systemic (poly-vascular) subclinical atherosclerosis are associated with impaired coronary microvascular function. Better coronary microvascular function reduces atherosclerosis progression at follow-up. (Progression of Early Subclinical Atherosclerosis PESA; NCT01410318).
Devesa et al. (Wed,) studied this question.